SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-036117
Filing Date
2021-05-26
Accepted
2021-05-26 21:01:59
Documents
2
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2821
2 POA DOCUMENT poa.txt EX-24.3_988521 2903
  Complete submission text file 0001209191-21-036117.txt   7264
Mailing Address C/O NEW LEAF VENTURE PARTNERS TIMES SQ TOWER, 7 TIMES SQ, STE 3502 NEW YORK NY 10036
Business Address
Becker Daniel J. (Reporting) CIK: 0001752139 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40431 | Film No.: 21968210

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations